
==== Front
Mol VisMVMolecular Vision1090-0535Molecular Vision 502007MOLVIS037618334962Research ArticlePresence of myocilin sequence variants in Japanese patients with open-angle glaucoma Mengkegale MingGe 1Fuse Nobuo 1Miyazawa Akiko 1Takahashi Kana 2Seimiya Motohiko 1Yasui Tomoki 3Tamai Makoto 1Nakazawa Toru 1Nishida Kohji 11 Department of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan2 Hiraka General Hospital, Akita, Japan3 Yasui Eye Clinic, Miyagi, JapanCorrespondence to: N. Fuse, Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan; Phone: 81-22-717-7294; FAX: 81-22-717-7298; email: hawkinschristine@example.com 04 3 2008 14 413 417 05 12 2007 22 2 2008 2008Molecular VisionThis is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.

Purpose
To examine the myocilin (MYOC) gene for mutations in Japanese patients with primary open-angle glaucoma (POAG) and to determine the phenotypes of the patients with the mutations.

Methods
One-hundred thirty-eight unrelated Japanese patients with POAG were studied. Genomic DNA was extracted from leukocytes of peripheral blood, and the three coding exons including the intron-exon boundaries were amplified by polymerase chain reaction (PCR) and directly sequenced bi-directionally.

Results
Two sequence variants were identified, one novel non-synonymous amino acid change (p.Gln297His) and one reported synonymous amino acid change (p.Ala363Thr). These mutations were not detected in the 118 ethnically-matched controls. p.Gln297His was found in a 70-year-old man, who developed POAG at a late age, and his intraocular pressure was high. p.Ala363Thr was found in two cases, and both patients developed POAG at an early age and had high intraocular pressures that responded poorly to medical treatment.

Conclusions
Two non-synonymous variants, p.Gln297His and p.Ala363Thr, indicate that they are involved in the pathogenesis of POAG. p.Ala363Thr has been found in another Japanese population and would be useful in genetic testing.

GalleyStatusExport to XML
==== Body
Introduction
Primary open-angle glaucoma (POAG) is a genetically heterogeneous disorder characterized by a progressive excavation of the optic disc and a loss of retinal nerve fiber leading to visual field defects. It is most likely a genetically heterogeneous disorder caused by the interaction of multiple genes and environmental factors [1,2]. Adult onset POAG is inherited as a complex trait while juvenile onset open-angle glaucoma (JOAG) has an early onset with high penetrance and an autosomal dominant mode of transmission [3].

To date, at least 14 loci from GLC1A to GLC1N have been linked to POAG, and three genes have been identified, the myocilin (MYOC) gene [4,5], the optineurin (OPTN) gene [6], and the WD repeat domain 36 (WDR36) gene [7]. Mutations of MYOC have been found in sporadic and familial cases of POAG worldwide, and their specific phenotype-genotype correlation has been characterized [5,8-24]. Overall, 2%–4% of POAG cases are due to MYOC mutations [10,15], although it might be as high as 22.2% [20] to 36% [18] in families with JOAG. MYOC encodes 504 amino acid residues [8] and is composed of three exons [25,26]. MYOC contains a myosin-like domain and an olfactomedin-like domain, and about 90% of the mutations are clustered in the region coding for the olfactomedin-like domain in exon 3 [5,8,9,11].

The types of mutations found in diverse ethnic populations are different, but the overall incidence of myocilin mutations is similar, which is about 2%–4% in all populations [15]. The most common mutation of MYOC is the p.Gln368Stop, which is found in Caucasians [12] and has not been detected in Japanese. This would suggest that the mutations in MYOC in the Japanese could be different from that of Caucasians and perhaps other ethnic populations.

For the other two glaucoma genes (OPTN and WDR36), the results of the screening were difficult to interpret. Thus, the MYOC gene is the only glaucoma gene that has been widely evaluated and is accepted to be a causal gene for glaucoma in many populations. The purpose of this study was to examine MYOC for mutations in Japanese patients with primary open-angle glaucoma (POAG) and to determine the phenotypes of the patients with these mutations.

Methods
One-hundred thirty-eight unrelated Japanese patients with POAG (72 men and 66 women; mean age 63.6±14.4 years), who were examined at the Ophthalmic Clinic of the Tohoku University Hospital, Sendai, Japan, were studied. The purpose and procedures were explained to all patients, and an informed consent was obtained. This study was approved by the Tohoku University Institutional Review Board, and the procedures used conformed to the tenets of the Declaration of Helsinki.

Routine ophthalmic examinations were performed on all patients. The criteria used for classifying a patient as having POAG were as follows: 1) applanation intraocular pressure (IOP) greater than 22 mmHg in each eye; 2) glaucomatous cupping in each eye including a cup-to-disc ratio greater than 0.7, 3) visual field defects determined by Goldmann perimetry and/or Humphrey field analyzer consistent with the glaucomatous cupping in at least one eye, and 4) an open anterior chamber angle. The mean IOP at diagnosis was 27.2±5.1 mmHg in the 138 patients with POAG. Patients with secondary glaucoma caused by trauma, uveitis, or steroid-induced were excluded.

Control subjects (62 men and 56 women; mean age 68.0±7.7 years) had the following characteristics: 1) an IOP of less than 22 mmHg, 2) normal optic discs, and 3) no family history of glaucoma. The mean IOP at the initial examination was 14.3±3.4 mmHg in the118 control patients.

Genomic DNA was extracted from peripheral blood leukocytes and purified with the Qiagen QIAamp Blood Kit (Qiagen, Valencia, CA). All three exons that code for a 504 amino acid protein were amplified by olymerase chain reaction (PCR). For the PCR, seven primer sets were used under standard PCR conditions (Table 1). The amplifications were performed at 58 °C annealing temperature. PCR fragments were purified by ExoSAP-IT (USB, Cleveland, OH) and sequenced by the BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) on an automated DNA sequencer (ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).

Table 1 Primer sequences used in this study.
Exon	Primer name	Primer sequence	
Exon 1	MYOC1–1F	GGCTGGCTCCCCAGTATATA	
	MYOC1–1R	CTGCTGAACTCAGAGTCCCC	
	MYOC1–2F	AATTGACCTTGGACCAGG	
	MYOC1–2R	CTCCAGAACTGACTTGTCTC	
Exon 2	MYOC2–1F	ACATAGTCAATCCTTGGGCC	
	MYOC2–1R	ATGAATAAAGACCATGTGGG	
Exon 3	MYOC3–1F	GGATTAAGTGGTGCTTCG	
	MYOC3–1R	AATACGGGAACTGTCCGTGG	
	MYOC3–2F	ATACTGCCTAGGCCACTGGA	
	MYOC3–2R	CATGCTGCTGTACTTATAGCGG	
	MYOC3–3F	GAACTCGAACAAACCTGGGA	
	MYOC3–3R	TGAGCATCTCCTTCTGCC	
The amplifications were performed at 58 °C annealing temperature. PCR fragments were purified by ExoSAP-IT (USB, Cleveland, OH) and sequenced by the BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) on an automated DNA sequencer (ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).

Results
Our results showed two MYOC variants. The first was a novel MYOC variant, a missense mutation at the third nucleotide in codon 297 (CAG>CAC) resulting in an amino acid substitution of glutamine by histidine (p.Gln297His). The second variant was a reported MYOC variant, a missense mutation at the first nucleotide of codon 363 (GCT>ACT) resulting in an amino acid substitution of alanine by threonine (p.Ala363Thr) [24]. These mutations were not detected in all normal controls.

Case 1 (p.Gln297His)
Case 1 was a 71-year-old man diagnosed with POAG at the age of 60 years. He has three brothers and four sisters, but none of them has a glaucoma history. His IOP at the time of diagnosis was 28 mmHg Oculus Dexter (OD), and 45 mmHg Oculus Sinister (OD). He underwent trabeculectomy in his left eye in 2002. In 2007, his best corrected visual acuity (BCVA) in both eyes was 20/40 in the right eye and light perception in the left eye. The optic disc showed characteristic glaucomatous changes with cup/disc ratios of 0.9 in the right eye and 1.0 in the left eye. His IOP was maintained between 20 and 24 mmHg in both eyes under antiglaucoma medication. Global indices of the visual field were a mean deviation (MD) of −7.48 dB by the Humphrey field analyzer in the right eye. The visual fields of the left eye could not be determined.

Case 2 (p.Ala363Thr)
Case 2 was a 60-year-old woman who was diagnosed with POAG in 1970 at the age of 24 years (Figure 1). She underwent trabeculectomy four times in her right eye and twice in her left eye from 1980 to 1981. In 1993, the visual acuity of her right eye and left eye was hand motion and counting finger, respectively. The optic discs had the characteristic changes of glaucoma with a cup/disc ratio of 1.0 OD and 0.9 OS. Her IOP was maintained between 15 and 18 mmHg in both eyes with antiglaucoma medication. Her sisters and brother also had glaucoma that was diagnosed before the age of 40 years (Figure 1), but no further medical record and no blood sample was available.

Figure 1 Pedigree of Case 2. Solid squares indicate the affected men, and solid circles indicate the affected women. An arrow points to the proband. The gray square indicates the ocular hypertension and glaucoma suspect. The family included six affected individuals.

The daughter of the proband was first examined for glaucoma in 1999 at the age of 24. Her BCVA was 30/20 Oculus Uterque (OU). Her IOP were 22 mmHg in both eyes. The optic disc was excavated with the cup/disc ratio of 0.8 in both eyes. Automated static perimetry (Humphrey; program 30–2) revealed a nasal step. Treatment was started with topical antiglaucomatous medications, and her IOP was maintained between 16 and 19 mmHg. Her father and sister were also examined and found not to have any mutations in MYOC.

Case 3 (p.Ala363Thr)
This patient was a 65-year-old woman diagnosed with POAG at the age of 44 years. Her brother had also been diagnosed with glaucoma (Figure 2) at the age of 48. As for her mother, no medical record was available regarding the hawkinschristine@example.com.

Figure 2 Pedigree of Case 3. Solid circles indicate the proband and affected mother, and the solid square indicates the affected brother. The white square indicates the father, who is an unaffected subject.

Her IOP at the time of diagnosis was 22–24 mmHg in both eyes. Her BCVA was 20/20 OU. The optic disc showed the characteristic glaucomatous changes in the right eye with a cup/disc ratio of 0.9–1.0, but the ratio was 0.2 in the left eye. Her IOP was maintained around 20 mmHg in both eyes with antiglaucoma medication. She did not undergo glaucoma surgery. In 2007, the optic disc showed optic atrophy with the full cupping in both eyes. Her visual acuity was hand motion in the right eye and 20/200 in the left eye. Goldmann perimetry showed paracentral residual visual fields in the right eye and absolute scotomas in more than one quadrant in the left eye. The proband and her brother were found to have the same p.Arg363Thr mutation.

Discussion
Our analyses detected two variants of MYOC in our Japanese patients with POAG. A novel MYOC variant, p.Gln297His, and a variant, p.Arg363Thr [19,24], which was reported earlier in Japanese patients, were found. The phenotypes of our POAG patients with the two variants were moderate to high IOP, aggressive course without treatment, poor response to topical medication, and moderate response to filtration surgery. The phenotype in these patients is consistent with the phenotype presented for other GLC1A families [3,27-33].

In general, Japanese patients with POAG caused by a MYOC mutation such as p.Pro370Leu [16] and p.Thr448Pro [17,23] show early-onset at the age 40 years or younger. On the other hand, the POAG caused by a p.Ile360Asn [21] mutation has a late-onset phenotype as it is with the p.Gln368Stop mutation found in Western countries [12,34]. The p.Ala363Thr was segregated as an autosomal dominant mutation (Figure 1 and Figure 2), and MYOC orthologs were conserved in humans, chimpanzees, rats, mice, and dogs (Figure 3). p.Gln297His alters the amino acid sequence on the charge (neutral to basic), and p.Ala363Thr alters the amino acid sequence on the polarity (nonpolar to polar). Thus, the conservation of MYOC orthologs and changes that alter the charge and polarity can be considered to be probable disease-causing mutations. However, the subject who had the p.Gln297His mutation did not show family history.

Figure 3 Multiple amino acid alignments and evolutionary conservation of p.Gln297 and p.Arg363 of MYOC variants. Protein domains of MYOC are shown. Gln297 and Arg363 (underlined) are conserved among five species, humans, chimpanzees, rats, mice, and dogs.

About 90% of the mutations are clustered in exon 3 of MYOC in different ethnic populations [15], and this incidence is the same in the Japanese population (Figure 4). In this study, MYOC mutations were found at the rate of 3/136 (2.2%), which is approximately the same as previous reports on the Japanese and other ethnic populations [15,19]. The p.Ala363Thr mutation was found in another Japanese population and thus may be useful to examine in genetic screening tests [19,24].

Figure 4 Mutation spectrum found in Japanese individuals. The black boxes indicate the three exons. Nine out of 11 mutations are located in exon 3, the olfactomedin-like domain. The two underlined mutations were found in this study.

Identification of MYOC mutations will allow early detection even before the elevation of IOP or the irreversible visual impairment due to damage of the optic nerve. More studies of the function and genotype-phenotype correlation of the MYOC gene are required to determine the pathophysiology of POAG.

Acknowledgments
This study was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government (N.F.; C-18591905), Tokyo, Japan. This study was supported by a grant to N.F. from the Imai Memorial Fund for Glaucoma Research. The authors thank Dr. Duco I. Hamasaki for editing the manuscript.
==== Refs
References
1 Raymond V  Molecular genetics of the glaucomas: mapping of the first five "GLC" loci. Am J Hum Genet 1997 60 272 7 9012399 
2 Sarfarazi M  Recent advances in molecular genetics of glaucomas. Hum Mol Genet 1997 6 1515-28-2421658 
3 Johnson AT Drack AV Kwitek AE Cannon RL Stone EM Alward WL   Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology 1993 100 524 9 8479711 
4 Sheffield VC Stone EM Alward WL Drack AV Johnson AT Streb LM Nichols BE  WLM A. Genetic linkage of familial open angle glaucoma to chromosome 1q21–31. Nat Genet 1993 4 47 50 8513321 
5 Stone EM Fingert JH Alward WL Nguyen TD Polansky JR Sunden SL Nishimura D Clark AF Nystuen A Nichols BE Mackey DA Ritch R Kalenak JW Craven ER Sheffield VC  Identification of a gene that causes primary open angle glaucoma. Science 1997 275 515-28-2421853 
6 Rezaie T Child A Hitchings R Brice G Miller L Coca-Prados M Heon E Krupin T Ritch R Kreutzer D Crick RP Sarfarazi M  Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002 295 1077 9 11834836 
7 Monemi S Spaeth G DaSilva A Popinchalk S Ilitchev E Liebmann J Ritch R Heon E Crick RP Child A Sarfarazi M  Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005 14 515-28-24217485 
8 Adam MF Belmouden A Binisti P Brezin AP Valtot F Bechetoille A Dascotte JC Copin B Gomez L Chaventre A Bach JF Garchon HJ  Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain in TIGR in familial open-angle glaucoma. Hum Mol Genet 1997 6 2091 7 9328473 
9 Suzuki Y Shirato S Taniguchi F Ohara K Nishimaki K Ohta S  Mutation in TIGR gene in familial open angle glaucoma in Japan. Am J Hum Genet 1997 61 1202 4 9345106 
10 Wiggs JL Allingham RR Vollrath D Jones KH De La Paz M Kern J Patterson K Babb VL Del Bono EA Broomer BW Pericak-Vance MA Haines JL  Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 1998 63 1549 52 9792882 
11 Rozsa FW Shimizu S Lichter PR Johnson AT Othman MI Scott K Downs CA Nguyen TD Polansky J Richards JE  GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein. Mol Vis 1998 4 20 9772276 
12 Allingham RR Wiggs JL De La Paz MA Vollrath D Tallett DA Broomer B Jones KH Del Bono EA Kern J Patterson K Haines JL Pericak-Vance MA  Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1998 39 2288 95 9804137 
13 Alward WL Fingert JH Coote MA Johnson AT Lerner SF Junqua D Durcan FJ McCartney PJ Mackey DA Sheffield VC Stone EM  Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998 338 1022 7 9535666 
14 Mansergh FC Kenna PF Ayuso C Kiang AS Humphries P Farrar GJ  Novel mutations in the TIGR gene in early and late onset open angle glaucoma. Hum Mutat 1998 11 515-28-2421427 
15 Fingert JH Heon E Liebmann JM Yamamoto T Craig JE Rait J Kawase K Hoh ST Buys YM Dickinson J Hockey RR Williams-Lyn D Trope G Kitazawa Y Ritch R Mackey DA Alward WL Sheffield VC Stone EM  Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 1999 8 899 905 10196380 
16 Taniguchi F Suzuki Y Shirato S Ohta S  Clinical phenotype of a japanese family with primary open angle glaucoma caused by a Pro370Leu mutation in the MYOC/TIGR gene. Jpn J Ophthalmol 1999 43 80 4 10340787 
17 Yokoyama A Nao-i N Date Y Nakazato M Chumann H Chihara E Sawada A Matsukawa S  Detection of a new TIGR gene mutation in a japanese family with primary open angle glaucoma. Jpn J Ophthalmol 1999 43 85 8 10340788 
18 Shimizu S Lichter PR Johnson AT Zhou Z Higashi M Gottfredsdottir M Othman M Moroi SE Rozsa FW Schertzer RM Clarke MS Schwartz AL Downs CA Vollrath D Richards JE  Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma. Am J Ophthalmol 2000 130 515-28-24214290 
19 Kubota R Mashima Y Ohtake Y Tanino T Kimura T Hotta Y Kanai A Tokuoka S Azuma I Tanihara H Inatani M Inoue Y Kudoh J Oguchi Y Shimizu N  Novel mutations in the myocilin gene in Japanese glaucoma patients. Hum Mutat 2000 16 270 10980537 
20 Faucher M Anctil JL Rodrigue MA Duchesne A Bergeron D Blondeau P Cote G Dubois S Bergeron J Arseneault R Morissette J Raymond V Quebec Glaucoma Network  Founder TIGR/myocilin mutations for glaucoma in the Quebec population. Hum Mol Genet 2515-28-2421 90 12189160 
21 Takahashi H Ohtake Y Kubota R Kimura I Miyata H Miyata K Tanino T Mashima Y  Two families with primary open-angle glaucoma associated with myocilin gene mutations. Nippon Ganka Gakkai Zasshi 2002 106 201 7 11979979 
22 Izumi K Mashima Y Obazawa M Ohtake Y Tanino T Miyata H Zhang Q Oguchi Y Tanaka Y Iwata T  Variants of the myocilin gene in Japanese patients with normal-tension glaucoma. Ophthalmic Res 2003 35 515-28-24218426 
23 Ishikawa K Funayama T Ohtake Y Tanino T Kurosaka D Suzuki K Ideta H Fujimaki T Tanihara H Asaoka R Naoi N Yasuda N Iwata T Mashima Y  Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography. J Glaucoma 2004 13 515-28-24214471 
24 Ohyama A Fujimaki T Kimura T Kawabata K Fujiki K Ishikawa K Mashima Y Murakami A  Clinical phenotype of a Japanese family with primary open-angle glaucoma caused by a Ala 363 Thr mutation in the MYOC gene. Nippon Ganka Gakkai Zasshi 2006 110 37 43 16491872 
25 Kubota R Noda S Wang Y Minoshima S Asakawa S Kudoh J Mashima Y Oguchi Y Shimizu N  A novel myosin-like protein (Myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping. Genomics 1997 41 360 9 9169133 
26 Ortego J Escribano J Coca-Prados M  Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin. FEBS Lett 1997 413 515-28-2421311 
27 Richards JE Lichter PR Boehnke M Uro JL Torrez D Wong D Johnson AT  Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome1q. Am J Hum Genet 1994 54 62 70 8279471 
28 Graff C Urbak S Jerndal T Wadelius C  Confirmation of linkage to 1q21–31 in a Danish autosomal dominant juvenile-onset glaucoma family and evidence of genetic heterogeneity. Hum Genet 1995 96 285 9 7649543 
29 Morissette J Cote G Anctil JL Plante M Amyot M Heon E Trope GE Weissenbach J Raymond V  A common gene for juvenile and adult-onset primary open-angle glaucoma confined on chromosome 1q. Am J Hum Genet 1995 56 1431 42 7762566 
30 Wiggs JL Del Bono EA Schuman JS Hutchinson BT Walton DS  Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21–31. Ophthalmology 1995 102 1782 9 9098278 
31 Johnson AT Richards JE Boehnke M Stringham HM Herman SB Wong DJ Lichter PR  Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome 1q. Ophthalmology 1996 103 515-28-2421692 
32 Meyer A Bechetoille A Valtot F Dupont de Dinechin S Adam MF Belmouden A Brezin AP Gomez L Bach JF Garchon HJ  Age-dependent penetrance and mapping of the locus for juvenile and early-onset open-angle glaucoma on chromosome 1q (GLC1A) in a French family. Hum Genet 1996 98 515-28-2421876 
33 Lichter PR Richards JE Boehnke M Othman M Cameron BD Stringham HM Downs CA Lewis SB Boyd BF  Juvenile glaucoma linked to the GLC1A gene on chromosome 1q in a Panamanian family. Am J Ophthalmol 1997 123 413 6 9063261 
34 Angius A Spinelli P Ghilotti G Casu G Sole G Loi A Totaro A Zelante L Gasparini P Orzalesi N Pirastu M Bonomi L  Myocilin Gln368stop mutation and advanced age as risk factors for late-onset primary open-angle glaucoma. Arch Ophthalmol 2000 118 674 9 10815160


{'source': 'PubMedDataset'}